Vitamin D3-led nutritional-ingredients and specialty biotech manufacturer supplying pharma, dietary-supplement, food/beverage, veterinary and animal-feed customers worldwide.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 14 | 14 | 14 | 14 | 14 | 15 | 15 | 14 |
| Reserves | 295 | 346 | 358 | 301 | 274 | 348 | 376 | 392 |
| Borrowings | 224 | 232 | 239 | 220 | 139 | 115 | 112 | 113 |
| Other Liabilities | 80 | 94 | 96 | 102 | 120 | 137 | 149 | 128 |
| Total Liabilities | 614 | 687 | 707 | 637 | 548 | 614 | 651 | 648 |
| AssetsFixed Assets | 200 | 263 | 299 | 267 | 269 | 227 | 219 | 220 |
| CWIP | 71 | 57 | 35 | 45 | 2 | 16 | 26 | 13 |
| Investments | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
| Other Assets | 342 | 367 | 373 | 321 | 277 | 372 | 406 | 414 |
| Total Assets | 614 | 687 | 707 | 637 | 548 | 614 | 651 | 648 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 90 | 34 | 63 | 43 | 116 | 105 | 41 | 93 |
| Cash from Investing | -97 | -44 | -41 | -26 | -55 | -16 | 0 | -43 |
| Cash from Financing | 12 | -47 | -1 | -22 | -41 | -91 | -51 | -42 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 55 | -34 | 7 | 6 | 76 | 86 | 38 | 63 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
FERMENTA · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.